Literature DB >> 26305653

Prostate Cancer Screening.

Scott E Eggener1, Adam S Cifu2, Chadi Nabhan3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26305653     DOI： 10.1001/jama.2015.8033

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

Review 1.  What's new in screening in 2015?

Authors:  Sigrid V Carlsson; Monique J Roobol
Journal:  Curr Opin Urol       Date:  2016-09       Impact factor: 2.309

Review 2.  Semen as a rich source of diagnostic biomarkers for prostate cancer: latest evidence and implications.

Authors:  Chenyu Mao; Yongfeng Ding; Nong Xu
Journal:  Mol Cell Biochem       Date:  2021-10-16       Impact factor: 3.396

3.  An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care.

Authors:  E David Crawford; Matt T Rosenberg; Alan W Partin; Matthew R Cooperberg; Michael Maccini; Stacy Loeb; Curtis A Pettaway; Neal D Shore; Paul Arangua; John Hoenemeyer; Mike Leveridge; Michael Leapman; Peter Pinto; Ian M Thompson; Peter Carroll; James Eastham; Leonard Gomella; Eric A Klein
Journal:  Urology       Date:  2016-07-19       Impact factor: 2.649

4.  Adherence to cancer screening guidelines in Australian survivors of allogeneic blood and marrow transplantation (BMT).

Authors:  Gemma Dyer; Stephen R Larsen; Nicole Gilroy; Lisa Brice; Matt Greenwood; Mark Hertzberg; Masura Kabir; Louisa Brown; Megan Hogg; Gillian Huang; John Moore; David Gottlieb; John Kwan; Jeff Tan; Christopher Ward; Ian Kerridge
Journal:  Cancer Med       Date:  2016-04-25       Impact factor: 4.452

Review 5.  Men's perspectives of prostate cancer screening: A systematic review of qualitative studies.

Authors:  Laura J James; Germaine Wong; Jonathan C Craig; Camilla S Hanson; Angela Ju; Kirsten Howard; Tim Usherwood; Howard Lau; Allison Tong
Journal:  PLoS One       Date:  2017-11-28       Impact factor: 3.240

Review 6.  Translating insights into tumor evolution to clinical practice: promises and challenges.

Authors:  Matthew W Fittall; Peter Van Loo
Journal:  Genome Med       Date:  2019-03-29       Impact factor: 11.117

7.  Long non-coding RNA NORAD promotes the prostate cancer cell extracellular vesicle release via microRNA-541-3p-regulated PKM2 to induce bone metastasis of prostate cancer.

Authors:  Chuan-Yi Hu; Juan Chen; Xin-Hua Qin; Pan You; Jie Ma; Jing Zhang; He Zhang; Ji-Dong Xu
Journal:  J Exp Clin Cancer Res       Date:  2021-03-16

8.  Prostate cancer in omics era.

Authors:  Nasrin Gholami; Amin Haghparast; Iraj Alipourfard; Majid Nazari
Journal:  Cancer Cell Int       Date:  2022-09-05       Impact factor: 6.429

9.  Assessment of the Diagnostic Accuracy of Biparametric Magnetic Resonance Imaging for Prostate Cancer in Biopsy-Naive Men: The Biparametric MRI for Detection of Prostate Cancer (BIDOC) Study.

Authors:  Lars Boesen; Nis Nørgaard; Vibeke Løgager; Ingegerd Balslev; Rasmus Bisbjerg; Karen-Cecilie Thestrup; Mads D Winther; Henrik Jakobsen; Henrik S Thomsen
Journal:  JAMA Netw Open       Date:  2018-06-01

Review 10.  Plant Bioactives and the Prevention of Prostate Cancer: Evidence from Human Studies.

Authors:  Tracey L Livingstone; Gemma Beasy; Robert D Mills; Jenny Plumb; Paul W Needs; Richard Mithen; Maria H Traka
Journal:  Nutrients       Date:  2019-09-18       Impact factor: 5.717
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.